257 related articles for article (PubMed ID: 36899894)
21. Fragile X and APP: a Decade in Review, a Vision for the Future.
Westmark CJ
Mol Neurobiol; 2019 Jun; 56(6):3904-3921. PubMed ID: 30225775
[TBL] [Abstract][Full Text] [Related]
22. iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.
Doers ME; Musser MT; Nichol R; Berndt ER; Baker M; Gomez TM; Zhang SC; Abbeduto L; Bhattacharyya A
Stem Cells Dev; 2014 Aug; 23(15):1777-87. PubMed ID: 24654675
[TBL] [Abstract][Full Text] [Related]
23. High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.
Kumari D; Swaroop M; Southall N; Huang W; Zheng W; Usdin K
Stem Cells Transl Med; 2015 Jul; 4(7):800-8. PubMed ID: 25999519
[TBL] [Abstract][Full Text] [Related]
24. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
[TBL] [Abstract][Full Text] [Related]
25. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
[TBL] [Abstract][Full Text] [Related]
26. Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.
Kumari D; Bhattacharya A; Nadel J; Moulton K; Zeak NM; Glicksman A; Dobkin C; Brick DJ; Schwartz PH; Smith CB; Klann E; Usdin K
Hum Mutat; 2014 Dec; 35(12):1485-94. PubMed ID: 25224527
[TBL] [Abstract][Full Text] [Related]
27. Cortical neurogenesis in fragile X syndrome.
Castrén ML
Front Biosci (Schol Ed); 2016 Jan; 8(1):160-8. PubMed ID: 26709905
[TBL] [Abstract][Full Text] [Related]
28. Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay.
Kurosaki T; Imamachi N; Pröschel C; Mitsutomi S; Nagao R; Akimitsu N; Maquat LE
Nat Cell Biol; 2021 Jan; 23(1):40-48. PubMed ID: 33420492
[TBL] [Abstract][Full Text] [Related]
29. Neuron-Specific FMRP Roles in Experience-Dependent Remodeling of Olfactory Brain Innervation during an Early-Life Critical Period.
Golovin RM; Vest J; Broadie K
J Neurosci; 2021 Feb; 41(6):1218-1241. PubMed ID: 33402421
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
Gerhardt J
Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
[TBL] [Abstract][Full Text] [Related]
31. Integrative Analysis Identifies Key Molecular Signatures Underlying Neurodevelopmental Deficits in Fragile X Syndrome.
Utami KH; Skotte NH; Colaço AR; Yusof NABM; Sim B; Yeo XY; Bae HG; Garcia-Miralles M; Radulescu CI; Chen Q; Chaldaiopoulou G; Liany H; Nama S; Peteri UA; Sampath P; Castrén ML; Jung S; Mann M; Pouladi MA
Biol Psychiatry; 2020 Sep; 88(6):500-511. PubMed ID: 32653109
[TBL] [Abstract][Full Text] [Related]
32. Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features.
Baker EK; Arpone M; Aliaga SM; Bretherton L; Kraan CM; Bui M; Slater HR; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field M; Cohen J; Cornish K; Santa Maria L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
Mol Autism; 2019; 10():21. PubMed ID: 31073396
[TBL] [Abstract][Full Text] [Related]
33. The feasibility and utility of hair follicle sampling to measure FMRP and FMR1 mRNA in children with or without fragile X syndrome: a pilot study.
Jalnapurkar I; Frazier JA; Roth M; Cochran DM; Foley A; Merk T; Venuti L; Ronco L; Raines S; Cadavid D
J Neurodev Disord; 2022 Dec; 14(1):57. PubMed ID: 36494616
[TBL] [Abstract][Full Text] [Related]
34. Directly reprogrammed fragile X syndrome dorsal forebrain precursor cells generate cortical neurons exhibiting impaired neuronal maturation.
Edwards N; Combrinck C; McCaughey-Chapman A; Connor B
Front Cell Neurosci; 2023; 17():1254412. PubMed ID: 37810261
[TBL] [Abstract][Full Text] [Related]
35. Functional changes of AMPA responses in human induced pluripotent stem cell-derived neural progenitors in fragile X syndrome.
Achuta VS; Möykkynen T; Peteri UK; Turconi G; Rivera C; Keinänen K; Castrén ML
Sci Signal; 2018 Jan; 11(513):. PubMed ID: 29339535
[TBL] [Abstract][Full Text] [Related]
36. Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis.
Khalfallah O; Jarjat M; Davidovic L; Nottet N; Cestèle S; Mantegazza M; Bardoni B
Stem Cells; 2017 Feb; 35(2):374-385. PubMed ID: 27664080
[TBL] [Abstract][Full Text] [Related]
37. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
Gao MM; Shi H; Yan HJ; Long YS
J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
[TBL] [Abstract][Full Text] [Related]
38. Increasing our understanding of human cognition through the study of Fragile X Syndrome.
Cook D; Nuro E; Murai KK
Dev Neurobiol; 2014 Feb; 74(2):147-77. PubMed ID: 23723176
[TBL] [Abstract][Full Text] [Related]
39. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
40. Modeling Fragile X syndrome in neurogenesis: An unexpected phenotype and a novel tool for future therapies.
Bardoni B; Capovilla M; Lalli E
Neurogenesis (Austin); 2017; 4(1):e1270384. PubMed ID: 28203608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
